Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain

Condition(s) studied

Investigational drug(s) / intervention(s)

Methylprednisolone Injection: Medication will be injected into SI joint under ultrasound guidance

Ketorolac Injection: Medication will be injected into SI joint under ultrasound guidance

Study summary

This study will contribute to the current literature that have compared joint injections with steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain. Currently steroid is the clinical standard for joint injections, however with repetitive use, steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory medication that does not cause the same joint damage and at a cheaper cost than steroid. The investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12 weeks post injection. This would allow more frequent injections to control pain at a decreased cost to the healthcare system.

Eligibility

Primary outcome measure(s)

• Sacroiliac (SI) joint pain — 3 months following SI joint injection
  SI joint pain at 2, 6 and 12 week marks post SI joint injection measured on visual analogue scale. Higher numbers equate to worse pain and worse outcomes.

Trial sites (1)

More McMaster University trials in Canada